AstraZeneca board approves delisting proposal
AstraZeneca board approves delisting proposal
Mumbai: AstraZeneca Pharma India Ltd said on Tuesday its board has approved a proposal to voluntarily delist the shares of the company from stock exchanges.
AstraZeneca Pharma AB, the parent company, holds 89.99% in AstraZeneca Pharma India.
Earlier in the day, shares of the company rose 20% to hit its daily upper trading limit after the company said it’s board will consider the delisitng proposal on Tuesday.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!